International programme seeks innovative health tech solutions

News

Author: Saskia MairPublished: 11 June 2020

Prep: Cook: Serves:

Zambon Open Accelerator 2019 awards ceremony

Open Accelerator, an international programme supporting digital healthcare technologies that improve patient experience, has launched its 2020 ‘Call for Solutions’.

Created by Zcube, the research venture of Italian pharmaceutical company Zambon, the accelerator focuses on four key areas: ‘digital prevention, monitoring and therapeutics’, ‘digital diagnostics’, ‘virtual health’ and ‘clinical trials digitalisation’. Successful applicants will take part in a four-week programme, and could win up to EUR €100,000 seed investment for their project. In response to the Covid-19 pandemic, a ‘Special Challenge’ will be dedicated to new forms of communication in healthcare.

Elena Zambon, creator of the programme said: “Digital solutions have never been such a vital support for patients and caregivers as they have at this time.

“This programme is yet another way in which we are pursuing with conviction our commitment to improving patients’ lives, integrating cure and care with a multidisciplinary approach.”

Submissions are open until 20 July 2020. To find out more about how to apply visit the Open Accelerator website.

For more information on the latest Parkinson’s research please visit the EPDA website.

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests

Last Month

Next Month

Go Back

Share this story

Comments

Advances

Moving to the beat: can techno help Parkinson’s patients walk better?

Here’s a good excuse for blasting out your favourite dance music

World Parkinson Congress 2019 Bloggers: Heather Kennedy

#WPC2019: We talk to American blogger Heather Kennedy

First Steps: making Parkinson’s “less scary”

The two-day programme is created by people with Parkinson’s, for people w

Is there a link between Parkinson’s disease and blood vessel dysfunction?

Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.

New swab test may help with Parkinson’s disease diagnosis

Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

International programme seeks innovative health tech solutions

News

Author: Saskia MairPublished: 11 June 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

Moving to the beat: can techno help Parkinson’s patients walk better?

Perspectives

World Parkinson Congress 2019 Bloggers: Heather Kennedy

Interviews

First Steps: making Parkinson’s “less scary”

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

International programme seeks innovative health tech solutions

News

Author: Saskia MairPublished: 11 June 2020

Last Month

Next Month

Share this story

Comments

Related articles

Advances

Moving to the beat: can techno help Parkinson’s patients walk better?

Perspectives

World Parkinson Congress 2019 Bloggers: Heather Kennedy

Interviews

First Steps: making Parkinson’s “less scary”

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

Sign in